MyAverix Finance
ST · Healthcare
Cantargia AB (CANTA)
Biotechnology
Cantargia AB (CANTA) is listed on ST in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $731.42M, P/E ratio is 4.60, net margin is 50.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CANTA
Cantargia AB (CANTA) — FAQ
What is Cantargia AB's market cap?
Cantargia AB (CANTA) has a reported market cap of $731.42M (data as of 2026-05-24).
What is CANTA's P/E ratio?
The price-to-earnings (P/E) ratio for Cantargia AB (CANTA) is 4.60 (data as of 2026-05-24).
Does Cantargia AB pay a dividend?
Dividend yield is not available in the current snapshot for Cantargia AB (CANTA). Check the MyAverix Finance app for the latest dividend data.
What sector is Cantargia AB in?
Cantargia AB (CANTA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CANTA listed on?
CANTA is listed on ST.
What is Cantargia AB's net margin?
Cantargia AB (CANTA) reports a net margin of 50.7% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.